Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SEATTLE, June 26, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc (OTCBB:TPIV) has announced it will present a poster at the Third Annual Cancer Vaccines and Active Immunotherapy Summit in Boston describing...
-
SEATTLE, June 13, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (TPIV.OB), a biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and...
-
SEATTLE, May 18, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has pleasure in announcing the appointment of James W. Fuller to the Board of Directors. James (Jim) Fuller has over 30 years of...
-
SEATTLE, May 4, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has announced that following recent IRB approval a Phase I Clinical Trial on a novel set of HER2/neu Class II antigens will start...
-
SEATTLE, April 30, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has pleasure in announcing the appointment of Mark Reddish to the Board of Directors. Mark is currently Vice President of...
-
SEATTLE, April 19, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has pleasure in announcing the appointment of George Cardona as a Strategic Advisor to the Board on corporate strategy and...
-
SEATTLE, Wash., April 16, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has announced that it has signed an Exclusive Agreement with the Mayo Foundation for Education & Research, Rochester,...
-
SEATTLE, April 11, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) has announced that Robert Florkiewicz, Ph.D., has been appointed Senior Director of Molecular Biology & Virology. "Bob has...
-
SEATTLE, Feb. 27, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a vaccine technologies company specializing in the development of innovative immunotherapeutics and vaccines in the areas of...
-
SEATTLE, Jan. 30, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), Chairman and CEO is pleased to provide this corporate update to our shareholders and other interested parties. I am pleased to...